Key Points - Rosen Law Firm announces class action lawsuit on behalf of Flotek Industries, Inc. investors - Faruqi & Faruqi, LLP reminds investors of the deadline to seek lead plaintiff role by October 26, 2026 - Bronstein, Gewirtz & Grossman LLC files class action lawsuit against Flotek Industries, Inc. - Kaplan Fox & Kilsheimer...
Key Points - Rosen Law Firm files class action lawsuit on behalf of Hyliion Holdings Corp....
Key Points - Multiple law firms alert investors of upcoming lead plaintiff deadline in ongoing securities...
American Outdoor Brands, Inc. (AOUT) - This analysis reviews how the stock price reacted after the...
Duluth Holdings Inc. (DLTH) - This analysis reviews how the stock price reacted after the last...
Laurence Alexander from Jefferies issued a price target of $26.00 for IPX on 2026-09-02 07:39:00.The adjusted price target was set to $26.00.At the time of the announcement, IPX was trading...
from Raymond James issued a price target of $87.00 for CHMG on 2026-09-01 20:15:15.The adjusted price target was set to $87.00.At the time of the announcement, CHMG was trading at...
from Lake Street issued a price target of $10.00 for XAIR on 2026-09-01 12:41:46.The adjusted price target was set to $10.00.At the time of the announcement, XAIR was trading at...
Salim Syed from Mizuho Securities issued a price target of $53.00 for ASMB on 2026-09-01 11:41:57.The adjusted price target was set to $53.00.At the time of the announcement, ASMB was...
Edward Nash from Canaccord Genuity issued a price target of $10.00 for ACRS on 2026-09-01 10:21:48.The adjusted price target was set to $10.00.At the time of the announcement, ACRS was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
